Baker Bros. Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
|
|||||
2023
Q3 | $8.38M | Hold |
|
|||||
2023
Q2 | $9.43M | Hold |
|
|||||
2023
Q1 | $12.3M | Hold |
|
|||||
2022
Q4 | $20.3M | Hold |
|
|||||
2022
Q3 | $34.3M | Hold |
|
|||||
2022
Q2 | $22.7M | Hold |
|
|||||
2022
Q1 | $46.5M | Hold |
|
|||||
2021
Q4 | $74.2M | Hold |
|
|||||
2021
Q3 | $86.9M | Hold |
|
|||||
2021
Q2 | $126M | Buy |
|
|||||
2021
Q1 | $97.2M | Hold |
|
|||||
2020
Q4 | $127M | Hold |
|
|||||
2020
Q3 | $88.8M | Sell |
|
|||||
2020
Q2 | $88.5M | Hold |
|
|||||
2020
Q1 | $70.7M | Hold |
|
|||||
2019
Q4 | $141M | Hold |
|
|||||
2019
Q3 | $111M | Hold |
|
|||||
2019
Q2 | $112M | Buy |
|
|||||
2019
Q1 | $123M | Hold |
|
|||||
2018
Q4 | $130M | Sell |
|
|||||
2018
Q3 | $159M | Hold |
|
|||||
2018
Q2 | $195M | Hold |
|
|||||
2018
Q1 | $139M | Buy |
|
|||||
2017
Q4 | $55.4M | Buy |
|
|||||
2017
Q3 | $45M | Buy |
|
|||||
2017
Q2 | $38.6M | Hold |
|
|||||
2017
Q1 | $41.8M | Buy |
|
|||||
2016
Q4 | $31.2M | Sell |
|
|||||
2016
Q3 | $49.2M | Hold |
|
|||||
2016
Q2 | $51.6M | Sell |
|
|||||
2016
Q1 | $55.2M | Hold |
|
|||||
2015
Q4 | $77.6M | Hold |
|
|||||
2015
Q3 | $71M | Buy |
|
|||||
2015
Q2 | $87.5M | Buy |
|
|||||
2015
Q1 | $37.9M | Hold |
|
|||||
2014
Q4 | $26.2M | Hold |
|
|||||
2014
Q3 | $21.7M | Hold |
|
|||||
2014
Q2 | $32.1M | Buy |
|
|||||
2014
Q1 | $30.2M | Buy |
|